Detection of molecular targets on the surface of CD34+/CD38-- stem cells in various myeloid malignancies. - Wikidata - awgldk - TriplyDB

Detection of molecular targets on the surface of CD34+/CD38-- stem cells in various myeloid malignancies.

Detection of molecular targets on the surface of CD34+/CD38-- stem cells in various myeloid malignancies.

http://www.wikidata.org/entity/Q53646273

about

Distribution and levels of cell surface expression of CD33 and CD123 in acute myeloid leukemia Cancer stem cells in basic science and in translational oncology: can we translate into clinical application?Fluorouracil selectively enriches stem-like leukemic cells in a leukemic cell line.SL-401 and SL-501, targeted therapeutics directed at the interleukin-3 receptor, inhibit the growth of leukaemic cells and stem cells in advanced phase chronic myeloid leukaemia.The elusive chronic myeloid leukemia stem cell: does it matter and how do we eliminate it?Identification and targeting leukemia stem cells: The path to the cure for acute myeloid leukemia.Novel targeted therapies for eosinophil-associated diseases and allergy Overexpression of IL-3Rα on CD34+CD38- stem cells defines leukemia-initiating cells in Fanconi anemia AML.CD34(+)/CD38(-) stem cells in chronic myeloid leukemia express Siglec-3 (CD33) and are responsive to the CD33-targeting drug gemtuzumab/ozogamicin The bone marrow microenvironment as a sanctuary for minimal residual disease in CML.Cellular imaging in drug discovery.Implications of cancer stem cells in the treatment of cancer.Identification of CD25 as STAT5-Dependent Growth Regulator of Leukemic Stem Cells in Ph+ CML.Small-molecule inhibition of BRD4 as a new potent approach to eliminate leukemic stem- and progenitor cells in acute myeloid leukemia AML.Epithelial ovarian cancer stem cells-a review.Clinical perspectives of concepts on neoplastic stem cells and stem cell-resistance in chronic myeloid leukemia.Novel targeted drug therapies for the treatment of childhood acute leukemia A neurosurgeon's guide to stem cells, cancer stem cells, and brain tumor stem cells.CD123 targeting oncolytic adenoviruses suppress acute myeloid leukemia cell proliferation in vitro and in vivo.Insights into the stem cells of chronic myeloid leukemia.Monoclonal antibody therapy directed against human acute myeloid leukemia stem cells.Pathogenesis, classification and treatment of mastocytosis: state of the art in 2010 and future perspectives.Molecular pathology of tumor-initiating cells: lessons from Philadelphia chromosome-positive leukemia.The proteomics of cancer stem cells: potential clinical applications for innovative research in oncology.Antibody therapy for acute myeloid leukaemia.DPPIV (CD26) as a novel stem cell marker in Ph+ chronic myeloid leukaemia.Current treatment options in patients with mastocytosis: status in 2015 and future perspectives.Cell surface markers of cancer stem cells: diagnostic macromolecules and targets for drug delivery.Novel approaches to pediatric leukemia treatment.Antigen-specific immunotherapy for acute myeloid leukemia: where are we now, and where do we go from here?Identification and Characterization of CD133(pos) Subpopulation Cells From a Human Laryngeal Cancer Cell Line Expression of CD25 on leukemic stem cells in BCR-ABL1+ CML: Potential diagnostic value and functional implications.Antileukemia Efficacy and Mechanisms of Action of SL-101, a Novel Anti-CD123 Antibody Conjugate, in Acute Myeloid Leukemia.Engineering a CD123xCD3 bispecific scFv immunofusion for the treatment of leukemia and elimination of leukemia stem cells.Quantitative assessment of the CD26+ leukemic stem cell compartment in chronic myeloid leukemia: patient-subgroups, prognostic impact, and technical aspects.Resistance to FLT3 inhibition in an in vitro model of primary AML cells with a stem cell phenotype in a defined microenvironment.Unravelling the relevance of CLEC12A as a cancer stem cell marker in myelodysplastic syndrome.Anti-Apoptotic Effects of Osteopontin via the Up-Regulation of AKT/mTOR/β-Catenin Loop in Acute Myeloid Leukemia Cells.miR‑181b‑5p mediates TGF‑β1-induced epithelial-to-mesenchymal transition in non-small cell lung cancer stem-like cells derived from lung adenocarcinoma A549 cells.Flow cytometric immunophenotyping of feline bone marrow cells and haematopoietic progenitor cells using anti-human antibodies.

P2860

Q27853019-FBCDDDB2-65F9-4745-A597-BB5C51E86717 Q28081844-0ACEE694-8152-452F-9252-1408268F6170 Q33660279-908E20E2-4A9B-45E4-A490-26E60B1DF2FB Q34098428-A5CDD5F4-94A4-4C21-9E0D-68E5018F750E Q34167708-B34BD0B2-6E3A-4B94-B3F6-6F687842937C Q34232877-672C81E9-9962-4C5F-8D99-48B42D609B36 Q34444620-F4DD8E13-8140-4EBE-B43A-D78F8DECFE5E Q34923690-F4F20400-6992-446C-8815-096BB5334E51 Q35717808-2783032E-BA68-43BF-8A3D-6B65C9816E57 Q35773205-41722023-36E7-4837-B85F-7372019FBE23 Q36438745-62BF1EEE-CBA2-417B-ABB9-91B6B5E34E19 Q36677482-F237A240-F35D-4AAD-9DFC-04A5490A3708 Q36755221-AF17A426-495D-4E6E-9337-E8021A7A1A3F Q36926120-9788AFD2-8F24-4758-98BE-90BAB1486044 Q36992785-DDE22B7E-9FF0-40A6-95C3-0E5D3C05E646 Q37132845-44F3B1EA-CBC4-457D-BA8E-9267F72036DF Q37477482-88216AF6-10DC-4EB5-83DA-2B3AEF4C4EC8 Q37559173-B16CDE25-80D5-482C-8BFE-9B83EE4300BE Q37679277-E5CDF550-59F8-4DBF-AA1F-6A5F143697E6 Q37791423-6C2D94D6-D81A-4649-8CA3-F3B246F8CF1B Q37809460-362B7B9E-8462-44F9-9A1B-FF0752C07909 Q37810130-2FD058FF-30D8-4427-B506-9E6ECB35F253 Q37925098-0D716A6F-DC88-48D0-8EB0-5469D444E90D Q37940376-D6DA254E-1409-466C-A35C-0E9F9FD46D4E Q38169814-D5B2BB91-31F1-4B3F-BDA8-284F36595993 Q38265115-19E14FAA-B25C-4BC2-BC4C-FF37167C8B07 Q38370943-B14936C7-3B26-4E98-828B-380E40553FF6 Q38383345-055592E0-BBF5-422D-829A-C461302BED5A Q38500371-AF083BB1-7CAC-435B-B099-AD0D696DB10F Q38700209-63DCCFC4-15C0-4CE9-BDF0-1C8695833BA3 Q38780361-26BDE416-9DD3-4FE2-ABBD-3D37D87E708B Q38812117-24E4A6DC-7535-437A-91D6-79FF29521AAC Q39016197-25B31947-3D4D-4613-B68F-EFF55E1F8450 Q39323781-24427CEE-2D1A-4DAA-BFD5-70A3F295E65C Q39795335-2B97FC3F-710D-4E19-A74D-34BC713F9098 Q39977455-08022E5C-8680-4FFB-A896-A648A6DE5853 Q40483682-7358D1DE-880E-440B-BEAA-F383F2FE2ED8 Q41543989-1BBA5CE6-7809-4790-AFC0-B1F4B91A2625 Q42207693-56234168-63ED-4011-AA5B-BC5A7E7B1DCC Q42267164-C9AF0A78-A094-420D-A214-1A88482F1C4B

P2860

Detection of molecular targets on the surface of CD34+/CD38-- stem cells in various myeloid malignancies.

http://www.wikidata.org/entity/Q53646273

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

Detection of molecular targets ...... various myeloid malignancies.

@en

Detection of molecular targets ...... various myeloid malignancies.

@nl

type

label

Detection of molecular targets ...... various myeloid malignancies.

@en

Detection of molecular targets ...... various myeloid malignancies.

@nl

prefLabel

Detection of molecular targets ...... various myeloid malignancies.

@en

Detection of molecular targets ...... various myeloid malignancies.

@nl

P1433

Q53646273-DC0D4149-DE65-4901-8F20-4B08FF8F113A

P1476

Q53646273-4D10B776-5BD7-4BAE-8A95-77A74832701A

P2093

Q53646273-0281DF58-129F-439F-8217-547311AC9620

Q53646273-09FCBFE7-DBC0-4A5D-A14F-B93C3A272197

Q53646273-0F138D59-2E85-4B17-A638-224545F3F2B5

Q53646273-612B492F-2B83-4F93-80F2-A6A16DBEA2F1

Q53646273-8FF8E270-329E-423F-AF8F-CEBE943FAE1E

Q53646273-D6DFD28D-193F-4F0F-BB98-DBD9F388F132

P2860

Q53646273-056BF76A-42F2-41E7-ADEC-B96E9D857ECC

Q53646273-0AF7BAC0-1866-4825-B12F-C942298267EC

Q53646273-114374E9-B342-4457-87D5-3507543F7DF1

Q53646273-1783378D-1968-4802-883F-2C1AFA2FC0CC

Q53646273-28C27FDF-C825-4014-A927-F01EA89FBAEE

Q53646273-2AE77DF5-5893-436F-8915-C00C72F8A6CC

Q53646273-2D3541C1-B5AC-4CD3-A650-C61A0E8F53D3

Q53646273-33C509BF-8A65-4AA7-86DD-8B2E42953918

Q53646273-3DAF88C0-4873-4899-951F-E9B2C11512EB

Q53646273-450B07B6-7FE1-48C4-9D61-19FF1029D196

P304

Q53646273-F98D0E24-68C4-4152-99E6-779180D65526

P31

Q53646273-4A389158-691B-41F0-8F26-DE8FBD1866AE

P356

Q53646273-03F5E3FF-D1B1-47DB-8AD1-C5E52D004E42

P433

Q53646273-507E4782-0353-4685-AA13-F4C6CA3C465A

P478

Q53646273-3DE8D331-457B-4B78-8CD2-FFF0B04E5A17

P50

Q53646273-8550E0E5-A999-408A-962B-E31DB4718E39

P577

Q53646273-5454AF7B-1763-4693-91E7-3D7C46A0D453

P698

Q53646273-8F01E65A-D43C-4A34-92FB-18DAF535A33C

P356

10428190500272507

P1433

Leukemia & Lymphoma

P1476

Detection of molecular targets ...... n various myeloid malignancies

@en

P2093

Alexander W Hauswirth

http://www.w3.org/2001/XMLSchema#string

Gerit-Holger Schernthaner

http://www.w3.org/2001/XMLSchema#string

Karoline Sonneck

http://www.w3.org/2001/XMLSchema#string

Maria-Theresa Krauth

http://www.w3.org/2001/XMLSchema#string

Stefan Florian

http://www.w3.org/2001/XMLSchema#string

Wolfgang R Sperr

http://www.w3.org/2001/XMLSchema#string

P2860

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

A cell initiating human acute myeloid leukaemia after transplantation into SCID mice

The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells

Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse

Proposals for the classification of the myelodysplastic syndromes

Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group

Diagnostic criteria and classification of mastocytosis: a consensus proposal.

Chronic myeloid disorders: Classification and treatment overview.

Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia.

Specific targeted therapy of chronic myelogenous leukemia with imatinib.

P304

207-222

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/10428190500272507

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16321850

http://www.w3.org/2001/XMLSchema#string